KinasePro

Kinase Chemistry – Just a year and a half behind the times.

kinasepro@gmail.com
Categories
- Abbott
- AKT
- Ambit
- Amgen
- Application List
- Approved
- Ariad
- Arqule
- Array
- Astellas
- Astex
- Astra
- Aurora
- Banyu
- bark
- Bayer
- bcr abl
- BI
- Biogen
- biotech
- Blogroll
- BMS
- c-fms
- c-Kit
- c-Met
- Camk
- CDC7
- CDK
- CDK2
- Celgene
- Cephalon
- Chiron
- Chk1
- CK1
- CK2
- clinical
- Cyclacel
- Deals
- Drug Like Properties
- EGF
- Eisai
- EphB4
- ERK
- Exelixis
- FAK
- Fgf
- Flt3
- Genentech
- General Interest
- gleevec
- Granted
- GSK
- GSK3
- HTG
- IGF
- IKK
- IND
- IRAK
- J&J
- JAK
- Janssen
- Jnk
- Lck
- Lexicon
- Lilly
- lyn
- meetings
- MEK
- Merck
- Merck & Co.
- Merck DE
- Millenium
- Mitsubishi
- Monday Night Off Topic
- mTor
- multi-target
- Nerviano
- Novartis
- OSI
- p38
- PDB
- PDGFR
- PDK1
- Pfizer
- Pharmacopeia
- Phase III
- pi3k
- pim1
- PKC
- Plexxikon
- Plk1
- Process
- RAF
- Rho
- Rigel
- Roche
- Sanofi-Aventis
- Schering AG
- Schering-Plough
- SGC
- SGX
- SRC
- SRI
- Sunesis
- Supergen
- SYK
- Takeda
- Tgf-b
- TIE2
- tpl2
- Trk
- Uncategorized
- VEGF
- Vertex
- Wee1
- Wyeth
- Zap70
Journals (beta)
- An error has occurred; the feed is probably down. Try again later.
Meta
Pages
- About 3.0
- Rule of 5
June 2017

M T W T F S S

« Jan

1 2 3 4

5 6 7 8 9 10 11

12 13 14 15 16 17 18

19 20 21 22 23 24 25

26 27 28 29 30
Archives
Blogroll

Blogroll

Meta
- Register
- Log in

Subscribe
- Entries (RSS)
- Comments (RSS)

Archive for the ‘IND’ Category

XL-019 = #14

Posted by kinasepro on May 24, 2007

IND application in the books.

First JAK2 inhibitor in development?

Posted in Exelixis, IND, JAK | 8 Comments »